Genmab A/s Earnings

Genmab A/s’s revenue fell -81.55% since last year same period to $1022Mn in the Q3 2025. On a quarterly growth basis, Genmab A/s has generated -82.56% fall in its revenue since last 3-months.

Genmab A/s’s net profit fell -68.33% since last year same period to $401Mn in the Q3 2025. On a quarterly growth basis, Genmab A/s has generated -81.17% fall in its net profits since last 3-months.

Genmab A/s’s net profit margin jumped 71.7% since last year same period to 39.24% in the Q3 2025. On a quarterly growth basis, Genmab A/s has generated 8.02% jump in its net profit margins since last 3-months.

Genmab A/s’s earning per share (EPS) estimates for the current quarter stand at 0.31 - a -27.14% fall from last quarter’s estimates.

Genmab A/s’s earning per share (EPS) estimates for the current year stand at 0.31.

Genmab A/s’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Genmab A/s has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.